The presence of microplastics in our food and soil has become a global-level crisis. A young girl named Anushka Sable has ...

Professor Markus Sauer from the Biocentre of Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany ...

In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of ...

Southampton scientists working to improve survival for cancer patients have identified a key characteristic of the disease ...

The human immune system is a complex network of cells and signals that guards against disease, yet in the case of cancer, it ...

Dendritic cells (DC) offer hope that the treatment of end-stage cancer will become much more successful in the near future.

This therapy is the first to activate specific components of the adaptive immune system, particularly CD4+ T helper cells, which are not known to be involved in traditional cancer treatments.

This study reports the molecular features and interactions of tumor and immune cells associated with two craniopharyngioma subtypes that will help identify future targeted therapeutics.

HIF1α identified as key regulator that induces cancer-killing ability of hypoxic T cells, playing a role in ICB resistance.

and immunosurveillance (e.g., cancer). The control of cytomegalovirus infection is demanding constant resources and affects the overall immune repertoire; this worsens with additional chronic ...

exerts dual effects on the tumor microenvironment (TME), necessitating integration with systemic therapies like immune checkpoint inhibitors (ICIs). Yet, therapeutic resistance, hypoxia-induced ...